Clinical Trials Contract Manufacturing Pharma Companies Pharma Production 
Pharmaceutical Technology
JULY 4, 2022
Although medicines tend to be excluded from trade sanctions as they cause loss of life, Russian pharma companies may struggle to secure funding in the face of economic sanctions and there may also be a disruption to non-essential medicines.
Pharmaceutical Technology
AUGUST 30, 2022
SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.
Expert insights. Personalized for you.
305 
Let's personalize your content